Last reviewed · How we verify
NCT05961852: CONCERTO
COmbiNing Cutting and Drug-Eluting Balloon for Resistant Arteriovenous Fistula sTenOsis (CONCERTO)
Phase 1 trial testing Angioplasty in Arteriovenous Fistula Stenosis in 19 participants. Completed in 30 June 2019.
30 June 2019
Quick facts
| Lead sponsor | Singapore General Hospital |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 19 |
| Start date | 15 August 2018 |
| Primary completion | 30 June 2019 |
| Estimated completion | 30 June 2019 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Angioplasty
Conditions studied
- Arteriovenous Fistula Stenosis — all drugs for Arteriovenous Fistula Stenosis →
Sponsor
Singapore General Hospital
Who can join
21 and older, any sex, with Arteriovenous Fistula Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the preliminary efficacy of combination of cutting and drug-coated balloon for the treatment of resistant AVF stenosis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Combining Cutting and Drug-eluting Balloon for Resistant Arteriovenous Fistula Stenosis (CONCERTO)-A Pilot Study.
Zhuang KD, Wei MWQ, Min SXCJ, Gogna A, et al · · 2025 · PMID 40384896 · DOI 10.22575/interventionalradiology.2024-0030
Verify or expand the search:
- PubMed search for NCT05961852
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Angioplasty
Trials testing the same drug.
- NCT06265324 — Drug-coated Balloon Treatment in Coronary Lesions · NA · unknown
- NCT05034939 — FLEX Vessel Prep Prior to Angioplasty in Native Arteriovenous Fistulae (AVF) · NA · completed
- NCT03471234 — Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE · completed
Other recruiting trials for Arteriovenous Fistula Stenosis
Currently open trials in the same condition.
- NCT06639451 — A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGE · NA · active not recruiting
- NCT06553443 — Randomised Clinical Trial Comparing Drug-coated Balloon to Plain Balloon for All Peripheral AVF Stenosis · Phase 3 · recruiting
Other Singapore General Hospital trials
Trials by the same sponsor.
- NCT07452159 — Diabetes In Asians at Risk in Youth · not yet recruiting
- NCT07527247 — Improving Vaccine Protection for Older Adults · Phase 2 · recruiting
- NCT07533188 — Patient Outcomes Following Kinematic and Functional Alignment in Robotic-Assisted Total Knee Arthroplasty With Randomize · NA · recruiting
- NCT07042061 — Trial of Mobile External Defibrillator for Out-of-hospital Cardiac Arrest in Singapore. · NA · not yet recruiting
- NCT07099040 — Community-based Multi-domain Intervention to Detect and Delay Cognitive Decline in Community-dwelling Older Adults: A Pi · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05961852 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Singapore General Hospital
- Last refreshed: 27 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05961852.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing